(9)In order to ensure the cooperation, in particular by exchange of information, of the Coordination Group with the expert panels on the preparation and update of joint clinical assessments of medical devices, in particular as regards the application of the selection criteria listed in Article 7(4) of Regulation (EU) 2021/2282, the HTA secretariat should inform the expert panels of the recommendation of the Coordination Group. Pursuant to Article 30 of Regulation (EU) 2022/123 of the European Parliament and of the Councilnote, the European Medicines Agency is acting as secretariat for those expert panels. Therefore, the exchange of information between the Coordination Group and the expert panels should be conducted via the HTA secretariat and the European Medicines Agency.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.